In response to growing environmental concerns and the demand for sustainable, functional food packaging, this study adopts a green nanotechnology approach by utilising phytochemically rich neem leaves to produce fluorescent and bioactive carbon dots (NLCDs). The NLCDs, prepared via a one-pot hydrothermal route, formed quasi-spherical nanostructures (∼8 nm) with abundant oxygen- and nitrogen-containing surface functional groups. These confer a strong electron-donating capacity, enabling the efficient scavenging of reactive oxygen species, while their quantum confinement and surface defect states underpin an excitation-dependent blue fluorescence (450 nm) and UV-vis absorption at 220 and 270 nm. When incorporated into a chitosan/polyvinyl alcohol (CP) matrix via solvent casting, the small size and uniform dispersion of NLCDs promoted strong hydrogen bonding and interfacial compatibility, as confirmed by FTIR, XRD, and SEM analyses. These reduced the polymer chain mobility, increasing the tensile strength by 66% (43.7 MPa) and enhancing the UV-blocking performance (93% attenuation at 280 nm). Antioxidant activity reached 82% (DPPH) and 77% (H2O2), attributable to the synergistic effects of NLCDs and the CP matrix. The films demonstrated potent antibacterial activity, with CPCD-3 inhibiting E. coli and S. aureus (15 mm and 12 mm zones) via membrane disruption and oxidative stress modulation, respectively. Biodegradation reached 94% in 100 days, and release studies showed sustained diffusion of NLCDs in food simulants. In prawn packaging trials, CPCD-3 preserved the pH (6.8–7.0), reduced the TVBN (28 mg/100 g), and maintained the microbial load (5 log CFU g−1) for over 15 days at 4 °C. These findings position NLCD-embedded CP films as next-generation, multifunctional active packaging materials with a clear mechanistic basis for their performance.
This study presents the development of biocompatible polymeric films designed for the sustained release of the β-blocker acebutolol hydrochloride (AH). The films were fabricated using chitosan (CH), a biodegradable biopolymer, in combination with varying concentrations of Averrhoa bilimbi leaf extract (ABE), a natural additive with potential antimicrobial properties. The composite films were characterized using crystallinity, spectroscopic, mechanical, thermal, and morphological analyses. Functional testing included swelling studies, cumulative drug release profiling, cytotoxicity assessments, and microbial resistance assessments. The results indicated that the incorporation of ABE positively influenced the structural, mechanical, thermal and morphological properties, including swelling behaviour, thickness, and drug release kinetics. The film with the lowest ABE concentration showed optimal swelling (∼200%) and the highest drug release (∼25%), along with notable drug loading (∼78%) and encapsulation efficiency (∼19%). The release kinetics followed the Higuchi and Korsmeyer–Peppas models, indicating a non-Fickian diffusion mechanism. Importantly, the AH integrity was maintained throughout the fabrication process, and all the films exhibited excellent biocompatibility (90% cell viability rate). These findings support the feasibility of using CH/ABE films as promising candidates for sustained drug delivery systems. The use of plant-based and biodegradable components underscores the potential of this green strategy in pharmaceutical formulations, contributing to sustainable chemistry and reducing the environmental impact in drug delivery applications.